Alteration of cytochrome P-450 by prolonged administration of imipramine and/or lithium to rats
- PMID: 2234106
- DOI: 10.1007/BF00166970
Alteration of cytochrome P-450 by prolonged administration of imipramine and/or lithium to rats
Abstract
The aim of this study was to investigate imipramine-induced alterations of cytochrome P-450 and to determine whether prolonged concomitant administration of imipramine and lithium results in a pharmacokinetic interaction. Male Wistar rats received imipramine (10 mg/kg i.p.) at 12 h intervals or lithium chloride (100 mg/kg in drinking water) or they were treated with the combination of these drugs for 2 weeks. The long term treatment with imipramine produced a very complex alteration of cytochrome P-450: imipramine increased the level of the cytochrome, but it decreased the rate of its own aromatic hydroxylation in position 2. The rate of N-demethylation in the side chain was not changed. Consequently, in the case of both hydroxylation and demethylation, calculated molecular activities were decreased to 48% and 70% respectively. This differential change in activities corresponded well to the observed decrease of absorption in difference spectra (type I) produced in microsomes by imipramine. Carbamazepine-induced type I difference spectra were also decreased by imipramine pretreatment, but to a lesser extent. In contrast, hexobarbital type I binding was increased by imipramine treatment while type II difference spectra produced by metyrapone were not affected. The preliminary SDS-PAGE analysis of cytochrome P-450 isoenzymes of control and imipramine treated rats showed that the investigated antidepressant markedly intensified a protein band at 50.11 kD while bands at 51.28 kD, 56.20 kD and 56.88 kD were less intensive. These results indicate that the alteration of cytochrome P-450 by imipramine treatment is not only of quantitative but also of qualitative character. Lithium alone given to rats affected neither the concentration of cytochrome P-450 in microsomal protein nor the rate of imipramine metabolism in vitro. Lithium given jointly with imipramine reduced imipramine-induced elevation of cytochrome P-450.(ABSTRACT TRUNCATED AT 250 WORDS)
Similar articles
-
Metabolic interaction between imipramine and carbamazepine in vivo and in vitro in rats.Naunyn Schmiedebergs Arch Pharmacol. 1988 Jan;337(1):105-10. doi: 10.1007/BF00169485. Naunyn Schmiedebergs Arch Pharmacol. 1988. PMID: 3368009
-
Pharmacokinetic interaction between imipramine and antidepressant neuroleptics in rats.Pol J Pharmacol Pharm. 1991 May-Jun;43(3):197-206. Pol J Pharmacol Pharm. 1991. PMID: 1683700
-
Effects of antidepressant drugs on the activity of cytochrome P-450 measured by caffeine oxidation in rat liver microsomes.Pol J Pharmacol. 2001 Jul-Aug;53(4):351-7. Pol J Pharmacol. 2001. PMID: 11990081
-
Effects of combined treatment with imipramine and metyrapone in the forced swimming test in rats. Behavioral and pharmacokinetic studies.Pol J Pharmacol. 2003 Nov-Dec;55(6):993-9. Pol J Pharmacol. 2003. PMID: 14730094
-
Imipramine: a model substance in pharmacokinetic research.Acta Psychiatr Scand Suppl. 1988;345:81-4. doi: 10.1111/j.1600-0447.1988.tb08572.x. Acta Psychiatr Scand Suppl. 1988. PMID: 3067542 Review.
Cited by
-
Clinical pharmacokinetics and metabolism of chloroquine. Focus on recent advancements.Clin Pharmacokinet. 1996 Oct;31(4):257-74. doi: 10.2165/00003088-199631040-00003. Clin Pharmacokinet. 1996. PMID: 8896943 Review.
-
Pharmacokinetics and metabolism of thioridazine during co-administration of tricyclic antidepressants.Br J Pharmacol. 2000 Sep;131(2):287-95. doi: 10.1038/sj.bjp.0703540. Br J Pharmacol. 2000. PMID: 10991922 Free PMC article.